Mediators of Inflammation
Volume 2017 (2017), Article ID 3827841, 7 pages
https://doi.org/10.1155/2017/3827841

Research Article

Transcriptional Profiling at High Temporal Resolution Reveals Robust Immune/Inflammatory Responses during Rat Sciatic Nerve Recovery

Lingyan Xing, Qiong Cheng, Guangbin Zha, and Sheng Yi

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China

Correspondence should be addressed to Sheng Yi; syi@ntu.edu.cn

Received 2 January 2017; Revised 25 February 2017; Accepted 7 March 2017; Published 12 April 2017

Academic Editor: Vera L. Petricevich

Copyright © 2017 Lingyan Xing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

After peripheral nerve injury, immune/inflammatory responses are triggered, which are critical for nerve regeneration. Despite their importance, the underlying molecular changes in immune/inflammatory responses remain largely unknown. In this study, we systematically analyzed differentially expressed genes in immune/inflammatory-related pathways at high temporal resolution and experimentally validated gene expression changes with RT-PCR following sciatic nerve crush in rats. We found that immune/inflammatory reactions not only occur in the acute injury but also remained activated over two weeks after injury. Detailed bioinformatic studies suggested that multiple immune/inflammatory pathways, including agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-6 signaling, and IL-10 signaling, were sustained activated during nerve degeneration and regeneration. Our current study expands our understanding of the molecular basis of altered immune/inflammatory-related pathways following injury and thus might offer the possibility of targeting related molecules as therapeutic intervention for peripheral nerve regeneration.

1. Introduction

Compared to the axons in the central nervous system, the peripheral nerves in adult mammals have great capacity for self-repair and regeneration. Successful peripheral regeneration depends on both the intrinsic growth capacity of peripheral axons and permissive microenvironment for axon growth [1, 2].

Peripheral nerve regeneration is a complex process that includes molecular changes in the immune/inflammatory pathways. In the process of axon degeneration, known as Wallerian degeneration, activated Schwann cells release cytokines and chemokines, which recruit the macrophages at the injury sites [3]. Accumulated macrophages further remove axonal and myelin debris, clearing a path for the subsequent axon regeneration [4]. Following peripheral nerve injury, both the innate and the acquired immune system are activated [5, 6]. Taken together, these previous studies indicated the importance of immune/inflammation responses in nerve injury.

Molecular changes in immune/inflammatory pathways following peripheral nerve injury were also identified. For example, the expression of various cytokines, including tumor necrosis factor (TNF), interleukin-6 (IL-6), and IL-10, are altered after nerve injury [7–11]. However, systematic analysis of gene expression changes in immune/inflammatory pathways and the related biological pathways during peripheral nerve injury and regeneration remain largely unclarified. In most cases, the functional recovery of severe peripheral nerve injury remains far from satisfactory. Therefore, it is necessary to obtain a better understanding of the roles of immune and inflammatory responses, which might help us find the molecular targets for posttraumatic nerve regeneration.

Our focus in this manuscript was on analyzing the molecular events in immune/inflammatory pathways following peripheral nerve injury in detail. Our previous work found that inflammatory and immune response-related functions, for example, immune cell trafficking and inflammatory response, were the top enriched categories following nerve injury [12]. Considering the importance of immune/inflammatory responses, in the current study, we further studied canonical pathways in immune/inflammation in detail. We found that four immune/inflammatory-related pathways, including agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-6 signaling, and IL-10 signaling, were sustained activated during the whole process of nerve regeneration. mRNA expression of multiple molecules in these pathways were further validated by RT-PCR.

2. Materials and Methods

2.1. Ethics Statement, Animal Surgery, and RNA Preparation

All animal procedures were performed in accordance with the guidelines of Nantong University and ethically approved by the Administration Committee of Experimental Animals, Jiangsu Province, China.

Animal surgery was performed as previously described [12]. Briefly, adult male Sprague Dawley (SD) rats, weighting 180–220 g, were randomly divided into 5 groups: 0, 1, 4, 7, and 14 days post injury. 75 rats were used for deep sequencing [12], while another 30 rats were used for RT-PCR. Anaesthetized animals were cut a skin incision in the left outer mid-thigh. The sciatic nerve was crushed three times for 10 seconds each by using a sterilized forceps. The muscle and skin were then sutured. The rats in the sham group underwent sham surgery on the left sciatic nerve prior to nerve samples being harvested. Sciatic nerve segments of 5 mm in length at the crush site were harvested and stored at −80°C. Total RNA was extracted from harvested nerve as previously described [12].

2.2. RNA Sequencing and Analysis

The deep sequencing performed was described in the previous paper [12]. Following deep sequencing, expression levels of mapped genes were calculated and normalized by reads per kilobase transcriptome per million mapped reads (RPKM) to eliminate the influence of gene lengths and sequencing discrepancy. Briefly, RPKM value of single gene was calculated with this formula: . C is the number of reads uniquely aligned to a particular gene, N is the total number of reads uniquely aligned to all genes, and L is the number of bases on a particular gene. Genes with a false discover rate and a fold are considered as differentially expressed at 1, 4, 7, and 14 days post sciatic nerve crush compared to sham group.

2.3. Bioinformatic Analysis

Differentially expressed genes were further uploaded to QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN) and analyzed according to the Ingenuity Pathways Knowledge Base (IPKB). Differentially expressed genes (DEGs) were subjected to diseases and cellular functions and canonical signaling pathway analysis. DEGs in agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-10 signaling, and IL-6 signaling were further analyzed and illustrated by the Venn diagram. A heatmap was generated using top over-represented DEGs based on the significance values ( values).

2.4. Real-Time PCR

RNA samples from 30 rats (different samples from what have been described in transcriptome sequencing) were used for real-time PCR to validate the results of transcriptome sequencing. The individual RNA sample (0.5 μg) was reverse transcribed to cDNA with the Prime-Script reagent Kit (TaKaRa, Dalian, China) and further amplified with SYBR Green Premix Ex Taq (TaKaRa) in Applied Biosystems Stepone machine with listed primer pairs (see Additional File available online at https://doi.org/10.1155/2017/3827841). Relative expression levels of mRNA were further quantified via the comparative 2−ΔΔCt method, in which 18S rRNA was used as a reference gene. For more details, check [12].

2.5. Statistical Analysis

Experimental outcomes were represented as mean ± SEM and all data were analyzed using GraphPad Prism 6.0 (GraphPad Software Inc.). One-way ANOVA was used to compare multiple groups and a was considered as significantly different.

3. Results

3.1. Diseases and Cellular Functions Analysis after Nerve Injury

Previously, we used a rat sciatic nerve crush model to analyze transcript changes from deep sequencing at 1, 4, 7, and 14 days following injury. We found 13,721, 14,321, 14,745, and 6979 DEGs compared to sham group, respectively [12].

We applied IPA to analyzed diseases and functions with DEGs. Top of these DEGs at injured nerves were highly enriched in hematological system development, cellular movement, inflammatory response, and immune cell trafficking (Figure 1, Additional Files , , and , and [12]). Most diseases and function were activated following nerve injury (Additional Files , , and ). We noticed that DEGs were enriched in immune/inflammatory responses at all four time points (1, 4, 7, and 14 days after injury) (Figure 1) [12].

Figure 1: Diseases and cellular functions of differentially expressed genes (DEGs) following nerve injury by IPA analysis. Top 10 diseases and biofunctions to be overrepresented by DEGs at 1, 4, 7, and 14 days post injury (dpi). The size of sectors is correlated to the number of DEGs.

3.2. Immune/Inflammatory-Related Canonical Signaling Pathways Post Nerve Injury

Further IPA canonical pathway analysis reveals that significantly dysregulated pathways in immune/inflammatory reactions following injury were agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-10 signaling, and IL-6 signaling (Table , Additional Files , , , , , , , and ) based on the score (−log ( value)) of each pathway ( were considered statistically significant). Agranulocyte/granulocyte adhesion and diapedesis are primary lines of host defense against infection, critical for recruiting agranulocytes and granulocytes to the injury sites. IL-6 is a proinflammatory cytokine, while IL-10 is an anti-inflammatory cytokine which limit and eliminate proinflammatory activity. Interestingly, pathways of agranulocyte adhesion and diapedesis (−log ( value) >14.2) and granulocyte adhesion and diapedesis (−log ( value) >13.1) are the top three canonical pathways dysregulated at all stages following injury (Table 1).

Table 1: Significance of agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-10 signaling, and IL-6 signaling at each time point following peripheral nerve injury. The −log ( value) and ratio of these signaling pathways were listed.

Agranulocyte adhesion and diapedesis
Rank
−log ( value)
Ratio
Number of differentially expressed genes

1 day
1
16.5
0.487
92

4 days
1
14.2
0.460
87

7 days
2
17.7
0.413
78

14 days
3
14.6
0.328
62

Granulocyte adhesion and diapedesis
Rank
−log ( value)
Ratio
Number of differentially expressed genes

1 day
2
13.7
0.469
83

4 days
3
13.1
0.458
81

7 days
1
17.9
0.424
75

14 days
1
16.1
0.350
62

IL-6 signaling
Rank
−log ( value)
Ratio
Number of differentially expressed genes

1 day
29
5.35
0.397
46

4 days
91
3.36
0.345
40

7 days
53
4.20
0.293
34

14 days
48
5.44
0.267
31

IL-10 signaling
Rank
−log ( value)
Ratio
Number of differentially expressed genes

1 day
7
8.74
0.544
37

4 days
38
5.40
0.456
31

7 days
22
6.78
0.412
28

14 days
30
8.07
0.382
26

When analyzing the DEGs at different time points, we found 46, 46, 26, and 24 genes commonly upregulated or downregulated in the pathways of agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis, IL-10 signaling, and IL-6 signaling, respectively (see the intersect in red, Figures 2(a), 2(b), 2(c), and 2(d)). Moreover, we also found that most DEGs in these pathways continuously either upregulated or downregulated, though most genes are upregulated following injury (Additional Files , , , and ), indicating that all time points post peripheral nerve injury share similar immune/inflammatory reactions.

(a)

(b)

(c)

(d)

Figure 2: Differential gene expression patterns in the pathways of agranulocyte adhesion and diapedesis (a), granulocyte adhesion and diapedesis (b), IL-6 signaling (c), and IL-10 signaling (d) at 1, 4, 7, and 14 days after injury shown as Venn diagrams. The intersection shows the overlapped DEGs.

3.3. qRT-PCR Validation of Genes in Immune/Inflammatory-Related Pathways

To validate RNA-seq results for individual genes, we performed RT-PCR with different sets of RNA samples used for transcriptome sequencing. In agranulocytes/granulocytes adhesion and diapedesis, inflammatory signals induce endothelial cells to exocytose P-selectin (SELP) and E-selectin (SELE). SELP and SELE bind to their respective ligands P-selectin glycoprotein ligand (SELPLG) and E-selectin ligand-1 (ESL1), mediating cell contact between agranulocytes or granulocytes and endothelial cells. L-selectin (SELL) is recognized by SELE or other molecules, leading to a rolling movement of the agranulocytes/granulocytes on the endothelial cell surface (Additional File A). This further activates integrins, including but not limit to, integrin α-4 (ITGA4) and ITGB7 (Additional File A) [13–15]. IL-6 signaling is critical in proinflammatory response. IL-6 binds to its receptor IL-6R, known as CD126, leading to activation of receptor-associated kinases, for example, Janus kinase 2 (JAK2) (Additional File B) [16]. IL-10 is an anti-inflammatory cytokine, which limits and terminates the inflammatory response, including IL-6 signaling (Additional File C) [17]. Pathways and molecules are summarized in Table 2. Based on the significant biological functions, we analyzed mRNA expression of SELL, SELE, SELP, SELPG, and ITGA4 in agranulocytes/granulocytes adhesion and diapedesis pathways; ITGB7 in agranulocytes adhesion and diapedesis pathway, JAK2 in IL-6 pathway; and IL-10 from five different time points. mRNA levels of IL-10, SELL, SELE, and ITGB7 were dramatically increased at 1 day after nerve injury but were slowly declined from day 4 (Figures 3(a), 3(c), 3(d), and 3(h)). JAK2, SELP, and SELPLG are sustained to be upregulated during peripheral nerve degeneration and regeneration (Figures 3(b), 3(e), and 3(f)). The expression of ITGA4 starts to increase until 4 days post injury and is continuously upregulated at 7 and 14 days post injury (Figure 3(g)). Most expression changes of these genes from the qRT-PCR results match the RNA-seq results, though RNA-seq is more sensitive to show the continuous upregulation of most genes tested at all different stages (Additional Files , , , and ).

Table 2: Molecules verified and pathways involved.

Molecules verified
Pathways
Function

SELP, SELE, SELPLG, SELL, ITGA4
Agranulocyte/granulocyte adhesion and diapedesis
Extravasation of agranulocyte/granulocyte, including (1) tethering, (2) rolling and activation, (3) firm adhesion to the endothelium, (4) diapedesis, and (5) transendothelial migration

ITGB7
Agranulocyte adhesion and diapedesis

JAK2
IL-6
Proinflammatory response

IL-10
IL-10
Anti-inflammatory response

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 3: Validation of RNA-seq results by quantitative real-time PCR (qRT-PCR). qRT-PCR was used to determine the differential gene expression at different time points. Data are analyzed with one-way ANOVA and presented as means ± SEM. , , and .

4. Discussion

We used a high-resolution time course analysis of transcriptional profiling to characterize and validate expression changes of genes linked to immune/inflammation reactions in sciatic nerve injury. We found that following peripheral nerve injury, immune and inflammation reactions are among the top enriched cellular functions (also seen in [12]). Signaling pathway analysis suggested that agranulocyte adhesion and diapedesis, granulocyte adhesion and diapedesis pathway, IL-6 signaling, and IL-10 signaling are the major immune/inflammation pathways upregulated during nerve degeneration and regeneration. Moreover, we found that multiple genes in these pathways are continuously upregulated following nerve injury. Our study suggests that recruitment of inflammatory cells to the injury sites is sustained following nerve injury and a more general role of immune/inflammatory system in peripheral nerve injury.

Both our RNA-seq and RT-PCR data show continuous upregulation of JAK2, which is consistent with the activated IL-6 signaling during nerve injury [9, 12], indicating the interaction between IL-6 and JAK2. mRNA expression is rapidly upregulated after day 1, while slowly declined in the following two weeks, comparable to what have been found before [8, 18]. This indicates that IL-10 may play a role rather than anti-inflammatory cytokine which stops proinflammatory signaling, for example, IL-6. Another possibility is discordant protein and mRNA expression of IL-10 [8]. RT-PCR shows that SELE, SELL, ITGA4, ITGB7, and IL-10 are upregulated only at certain time points, but our RNA-seq data reveal that all genes tested are continuously upregulated following injury (Additional Files , , , and ), indicating RNA-seq is more sensitive to show the statistical difference. Protein levels should be further determined by Western blot. In addition, though these genes are sustained upregulated shown by RNA-seq, the fold changes compared to sham group are temporal-specific. The fold changes of these mRNA molecules in immune/inflammatory pathways might account for the dynamic responses in immune/inflammatory system following injury.

The activation of immune response seems beneficial for peripheral nerve regeneration, based on the observation that regeneration was severely attenuated with elimination of macrophages and neutrophils [1, 19]. The influences of inflammation on the spinal cord, however, are considered as destructive. Some molecules (e.g., TNF) are upregulated and toxic to neurons [20]. In our study, we also find sustained activation of TNF in the injured peripheral nerve (Additional File ), indicating the single molecule change cannot account for the general role of the immune system in peripheral nerve regeneration. Therefore, our systematic analysis of transcriptome is compelling to study the effects of the immune system in peripheral nerve regeneration.

We find even at 14 days post injury, immune/inflammatory pathways are still active. Whether this activation has negative effects that impede functional recovery requires further analysis. Moreover, further studies should also clarify the complex interactions between these inflammatory mediators and the specific contribution of each to peripheral nerve damage and repair.

The data sets supporting the results of this article are included within the article and its additional files.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

Sheng Yi conceived and designed the experiments. Lingyan Xing, Guangbin Zha, Qiong Cheng, and Sheng Yi performed the experiments. Lingyan Xing and Sheng Yi analyzed the data. Sheng Yi and Qiong Cheng contributed the reagents, materials, and analysis tools. Lingyan Xing and Sheng Yi wrote the manuscript. The manuscript has been approved by all authors.

Acknowledgments

This study was supported by the Natural Science Foundation of Jiangsu Province, China (Grant no. BK20150409), National Natural Science Foundation of China (81501058), Natural Science Foundation of Jiangsu Higher Education Institutions of China (Grant nos. 15KJB180013 and 15KJB310014), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

References

B. Barrette, M.-A. Hébert, M. Filali et al., “Requirement of myeloid cells for axon regeneration,” The Journal of Neuroscience, vol. 28, no. 38, pp. 9363–9376, 2008.

D. W. Zochodne, “The microenvironment of injured and regenerating peripheral nerves,” Muscle & Nerve. Supplement, vol. 9, pp. S33–S38, 2000, December 2, 2016http://www.ncbi.nlm.nih.gov/pubmed/11135282.

F. Fregnan, L. Muratori, A. R. Simões, M. G. Giacobini-Robecchi, and S. Raimondo, “Role of inflammatory cytokines in peripheral nerve injury,” Neural Regeneration Research, vol. 7, no. 29, pp. 2259–2266, 2012.

V. H. Perry and M. C. Brown, “Role of macrophages in peripheral nerve degeneration and repair,” BioEssays, vol. 14, no. 6, pp. 401–406, 1992.

A. L. Bombeiro, J. C. Santini, R. Thomé et al., “Enhanced immune response in immunodeficient mice improves peripheral nerve regeneration following axotomy,” Frontiers in Cellular Neuroscience, vol. 10, p. 151, 2016.

C. R. Cámara-Lemarroy, F. J. Guzmán-De La Garza, and N. E. Fernández-Garza, “Molecular inflammatory mediators in peripheral nerve degeneration and regeneration,” Neuroimmunomodulation, vol. 17, no. 5, pp. 314–324, 2010.

T. Cheepudomwit, E. Güzelsu, C. Zhou, J. W. Griffin, and A. Höke, “Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons,” Neuroscience Letters, vol. 430, no. 3, pp. 230–235, 2008.

A. George, C. Kleinschnitz, M. Zelenka, J. Brinkhoff, G. Stoll, and C. Sommer, “Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein,” Experimental Neurology, vol. 188, no. 1, pp. 187–191, 2004.

R. Lara-Ramírez, E. Segura-Anaya, A. Martínez-Gómez, and M. A. R. Dent, “Expression of interleukin-6 receptor α in normal and injured rat sciatic nerve,” Neuroscience, vol. 152, no. 3, pp. 601–608, 2008.

S. Shamash, F. Reichert, and S. Rotshenker, “The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta,” The Journal of Neuroscience, vol. 152, pp. 601–608, 2002.

N. Üçeyler, A. Tscharke, and C. Sommer, “Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain,” Brain, Behavior, and Immunity, vol. 21, no. 5, pp. 553–560, 2007.

S. Yi, H. Zhang, L. Gong et al., “Deep sequencing and bioinformatic analysis of lesioned sciatic nerves after crush injury,” PLoS ONE, vol. 10, no. 12, Article ID e0143491, 2015.

S. R. Barthel, J. D. Gavino, L. Descheny, and C. J. Dimitroff, “Targeting selectins and selectin ligands in inflammation and cancer,” Expert Opinion on Therapeutic Targets, vol. 11, no. 11, pp. 1473–1491, 2007.

E. Maverakis, K. Kim, M. Shimoda et al., “Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review,” Journal of Autoimmunity, vol. 57, pp. 1–13, 2015.

C. Strell and F. Entschladen, “Extravasation of leukocytes in comparison to tumor cells,” Cell Communication and Signaling: CCS, vol. 6, p. 10, 2008.

C. A. Hunter and S. A. Jones, “IL-6 as a keystone cytokine in health and disease,” Nature Immunology, vol. 16, no. 5, pp. 448–457, 2015.

P. Chatterjee, V. L. Chiasson, K. R. Bounds, and B. M. Mitchell, “Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy,” Frontiers in Immunology, vol. 5, p. 253, 2014.

C. Gillen, S. Jander, and G. Stoll, “Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration,” Journal of Neuroscience Research, vol. 51, no. 4, pp. 489–496, 1998.

S. Nadeau, M. Filali, J. Zhang et al., “Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1 and TNF: implications for neuropathic pain,” The Journal of Neuroscience, vol. 31, no. 35, pp. 12533–12542, 2011.

L. I. Benowitz and P. G. Popovich, “Inflammation and axon regeneration,” Current Opinion in Neurology, vol. 24, no. 6, pp. 577–583, 2011.